{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:44:20Z","timestamp":1782920660839,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00399-025-01098-2","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T10:58:12Z","timestamp":1754391492000},"page":"186-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of channelopathies in children","Management von Ionenkanalerkrankungen bei Kindern"],"prefix":"10.1007","volume":"36","author":[{"given":"Ulrich","family":"Krause","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"issue":"11","key":"1098_CR1","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1016\/j.hrthm.2019.09.019","volume":"16","author":"JA Towbin","year":"2019","unstructured":"Towbin\u00a0JA, McKenna\u00a0WJ, Abrams\u00a0DJ, Ackerman\u00a0MJ, Calkins\u00a0H et\u00a0al (2019) 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary. Heart Rhythm 16(11):e373\u2013e407","journal-title":"Heart Rhythm"},{"issue":"4","key":"1098_CR2","doi-asserted-by":"publisher","first-page":"e005797","DOI":"10.1161\/CIRCEP.117.005797","volume":"11","author":"SB Clur","year":"2018","unstructured":"Clur\u00a0SB, Vink\u00a0AS, Etheridge\u00a0SP, Robles de Medina\u00a0PG, Rydberg\u00a0A et\u00a0al (2018) Left ventricular Isovolumetric relaxation time is prolonged in fetal long-QT syndrome. Circ Arrhythm Electrophysiol 11(4):e5797","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"18","key":"1098_CR3","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","volume":"120","author":"PJ Schwartz","year":"2009","unstructured":"Schwartz\u00a0PJ, Stramba-Badiale\u00a0M, Crotti\u00a0L, Pedrazzini\u00a0M, Besana\u00a0A et\u00a0al (2009) Prevalence of the congenital long-QT syndrome. Circulation 120(18):1761\u20131767","journal-title":"Circulation"},{"issue":"1","key":"1098_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-020-0188-7","volume":"6","author":"PJ Schwartz","year":"2020","unstructured":"Schwartz\u00a0PJ, Ackerman\u00a0MJ, Antzelevitch\u00a0C, Bezzina\u00a0CR, Borggrefe\u00a0M et\u00a0al (2020) Inherited cardiac arrhythmias. Nat Rev Dis Primers 6(1):58","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"1098_CR5","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1161\/01.CIR.88.2.782","volume":"88","author":"PJ Schwartz","year":"1993","unstructured":"Schwartz\u00a0PJ, Moss\u00a0AJ, Vincent\u00a0GM, Crampton\u00a0RS (1993) Diagnostic criteria for the long QT syndrome. An update. Circulation 88(2):782\u2013784","journal-title":"Circulation"},{"issue":"40","key":"1098_CR6","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1093\/eurheartj\/eht089","volume":"34","author":"PJ Schwartz","year":"2013","unstructured":"Schwartz\u00a0PJ, Ackerman\u00a0MJ (2013) The long QT syndrome: a\u00a0transatlantic clinical approach to diagnosis and therapy. Eur Heart\u00a0J 34(40):3109\u20133116","journal-title":"Eur Heart J"},{"key":"1098_CR7","doi-asserted-by":"crossref","unstructured":"Samples S, Cherny S, Madan N, Hong J, Mansukhani SA et\u00a0al (2025) The prenatal diagnosis and Perinatal management of congenital long QT syndrome: a\u00a0comprehensive literature review and recent updates. J\u00a0Cardiovasc Dev Dis 12(4)","DOI":"10.3390\/jcdd12040156"},{"issue":"8","key":"1098_CR8","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/europace\/euac030","volume":"24","author":"AAM Wilde","year":"2022","unstructured":"Wilde\u00a0AAM, Semsarian\u00a0C, Marquez\u00a0MF, Shamloo\u00a0AS, Ackerman\u00a0MJ et\u00a0al (2022) European heart rhythm association (EHRA)\/heart rhythm society (HRS)\/asia pacific heart rhythm society (APHRS)\/latin American heart rhythm society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases. Europace 24(8):1307\u20131367","journal-title":"Europace"},{"issue":"7","key":"1098_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1089\/gtmb.2012.0118","volume":"17","author":"KV Lieve","year":"2013","unstructured":"Lieve\u00a0KV, Williams\u00a0L, Daly\u00a0A, Richard\u00a0G, Bale\u00a0S et\u00a0al (2013) Results of genetic testing in 855 consecutive unrelated patients referred for long QT syndrome in a\u00a0clinical laboratory. Genet Test Mol Biomarkers 17(7):553\u2013561","journal-title":"Genet Test Mol Biomarkers"},{"issue":"20","key":"1098_CR10","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.jacc.2012.07.046","volume":"60","author":"P Chockalingam","year":"2012","unstructured":"Chockalingam\u00a0P, Crotti\u00a0L, Girardengo\u00a0G, Johnson\u00a0JN, Harris\u00a0KM et\u00a0al (2012) Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J\u00a0Am Coll Cardiol 60(20):2092\u20132099","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1098_CR11","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/europace\/eut272","volume":"15","author":"SG Priori","year":"2013","unstructured":"Priori\u00a0SG, Wilde\u00a0AA, Horie\u00a0M, Cho\u00a0Y, Behr\u00a0ER et\u00a0al (2013) Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 15(10):1389\u20131406","journal-title":"Europace"},{"issue":"6","key":"1098_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00392-024-02383-9","volume":"113","author":"N Alhourani","year":"2024","unstructured":"Alhourani\u00a0N, Wolfes\u00a0J, Konemann\u00a0H, Ellermann\u00a0C, Frommeyer\u00a0G et\u00a0al (2024) Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias. Clin Res Cardiol 113(6):791\u2013800","journal-title":"Clin Res Cardiol"},{"issue":"17","key":"1098_CR13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.jacc.2008.01.033","volume":"51","author":"CI Berul","year":"2008","unstructured":"Berul\u00a0CI, Van Hare\u00a0GF, Kertesz\u00a0NJ, Dubin\u00a0AM, Cecchin\u00a0F et\u00a0al (2008) Results of a\u00a0multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J\u00a0Am Coll Cardiol 51(17):1685\u20131691","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1098_CR14","doi-asserted-by":"publisher","first-page":"263\u20136","DOI":"10.1016\/S0002-9149(98)00834-0","volume":"83","author":"MS Link","year":"1999","unstructured":"Link\u00a0MS, Hill\u00a0SL, Cliff\u00a0DL, Swygman\u00a0CA, Foote\u00a0CB et\u00a0al (1999) Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol 83(2):263\u20136\u2013A5\u20136","journal-title":"Am J Cardiol"},{"issue":"1","key":"1098_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/europace\/euy219","volume":"21","author":"U Krause","year":"2019","unstructured":"Krause\u00a0U, Muller\u00a0MJ, Wilberg\u00a0Y, Pietzka\u00a0M, Backhoff\u00a0D et\u00a0al (2019) Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks? Europace 21(1):106\u2013113","journal-title":"Europace"},{"issue":"2","key":"1098_CR16","doi-asserted-by":"publisher","first-page":"e010557","DOI":"10.1161\/CIRCEP.121.010557","volume":"15","author":"A Zahedivash","year":"2022","unstructured":"Zahedivash\u00a0A, Hanisch\u00a0D, Dubin\u00a0AM, Trela\u00a0A, Chubb\u00a0H et\u00a0al (2022) Implantable Cardioverter Defibrillators in infants and toddlers: indications, placement, programming, and outcomes. Circ Arrhythm Electrophysiol 15(2):e10557","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"13","key":"1098_CR17","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.jacep.2017.08.017","volume":"3","author":"M Bettin","year":"2017","unstructured":"Bettin\u00a0M, Larbig\u00a0R, Rath\u00a0B, Fischer\u00a0A, Frommeyer\u00a0G et\u00a0al (2017) Long-term experience with the subcutaneous Implantable Cardioverter-Defibrillator in teenagers and young adults. JACC Clin Electrophysiol 3(13):1499\u20131506","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"1098_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","volume":"106","author":"SG Priori","year":"2002","unstructured":"Priori\u00a0SG, Napolitano\u00a0C, Memmi\u00a0M, Colombi\u00a0B, Drago\u00a0F et\u00a0al (2002) Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106(1):69\u201374","journal-title":"Circulation"},{"issue":"11","key":"1098_CR19","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.hrthm.2021.07.061","volume":"18","author":"D Kallas","year":"2021","unstructured":"Kallas\u00a0D, Roston\u00a0TM, Franciosi\u00a0S, Brett\u00a0L, Lieve\u00a0KVV et\u00a0al (2021) Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 18(11):1825\u20131832","journal-title":"Heart Rhythm"},{"key":"1098_CR20","doi-asserted-by":"crossref","unstructured":"Behr ER, Winkel BG, Ensam B, Alfie A, Arbelo E et\u00a0al (2025) The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a\u00a0clinical consensus statement of the European heart rhythm association and the European association of Percutaneous cardiovascular interventions (EAPCI) of the ESC, the ESC working group on cardiovascular Pharmacotherapy, the association of European Paediatric and congenital cardiology (AEPC), the Paediatric & congenital Electrophysiology society (PACES), the heart rhythm society (HRS), the asia pacific heart rhythm society (APHRS), and the latin American heart rhythm society (LAHRS). Europace 27(4)","DOI":"10.1093\/europace\/euaf067"},{"issue":"5","key":"1098_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.121.056018","volume":"145","author":"PJ Peltenburg","year":"2022","unstructured":"Peltenburg\u00a0PJ, Kallas\u00a0D, Bos\u00a0JM, Lieve\u00a0KVV, Franciosi\u00a0S et\u00a0al (2022) An international multicenter cohort study on beta-blockers for the treatment of symptomatic children with Catecholaminergic polymorphic ventricular tachycardia. Circulation 145(5):333\u2013344","journal-title":"Circulation"},{"issue":"25","key":"1098_CR22","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.123.064786","volume":"148","author":"AT Bergeman","year":"2023","unstructured":"Bergeman\u00a0AT, Lieve\u00a0KVV, Kallas\u00a0D, Bos\u00a0JM, Roses\u00a0INF et\u00a0al (2023) Flecainide is associated with a\u00a0lower incidence of Arrhythmic events in a\u00a0large cohort of patients with Catecholaminergic polymorphic ventricular tachycardia. Circulation 148(25):2029\u20132037","journal-title":"Circulation"},{"issue":"11","key":"1098_CR23","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.hrthm.2021.07.038","volume":"18","author":"MJ Shah","year":"2021","unstructured":"Writing Committee M, Shah\u00a0MJ, Silka\u00a0MJ, Silva\u00a0JNA, Balaji\u00a0S et\u00a0al (2021) 2021 PACES expert consensus statement on the indications and management of cardiovascular Implantable electronic devices in pediatric patients. Heart Rhythm 18(11):1888\u20131924","journal-title":"Heart Rhythm"},{"issue":"40","key":"1098_CR24","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K, Tfelt-Hansen\u00a0J, de Riva\u00a0M, Winkel\u00a0BG, Behr\u00a0ER et\u00a0al (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart\u00a0J 43(40):3997\u20134126","journal-title":"Eur Heart J"},{"issue":"6","key":"1098_CR25","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","volume":"20","author":"P Brugada","year":"1992","unstructured":"Brugada\u00a0P, Brugada\u00a0J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a\u00a0distinct clinical and electrocardiographic syndrome. A\u00a0multicenter report. J\u00a0Am Coll Cardiol 20(6):1391\u20131396","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1098_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00399-023-00983-y","volume":"35","author":"L Eckardt","year":"2024","unstructured":"Eckardt\u00a0L, Veltmann\u00a0C (2024) More than 30\u00a0years of Brugada syndrome: a\u00a0critical appraisal of achievements and open issues. Herzschrittmacherther Elektrophysiol 35(1):9\u201318","journal-title":"Herzschrittmacherther Elektrophysiol"},{"issue":"3","key":"1098_CR27","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jacep.2021.12.001","volume":"8","author":"AD Krahn","year":"2022","unstructured":"Krahn\u00a0AD, Behr\u00a0ER, Hamilton\u00a0R, Probst\u00a0V, Laksman\u00a0Z et\u00a0al (2022) Brugada Syndrome. JACC Clin Electrophysiol 8(3):386\u2013405","journal-title":"JACC Clin Electrophysiol"},{"issue":"6673","key":"1098_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/32675","volume":"392","author":"Q Chen","year":"1998","unstructured":"Chen\u00a0Q, Kirsch\u00a0GE, Zhang\u00a0D, Brugada\u00a0R, Brugada\u00a0J et\u00a0al (1998) Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392(6673):293\u2013296","journal-title":"Nature"},{"issue":"6","key":"1098_CR29","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1017\/S1047951116000548","volume":"26","author":"MC Gonzalez Corcia","year":"2016","unstructured":"Gonzalez Corcia\u00a0MC, de Asmundis\u00a0C, Chierchia\u00a0GB, Brugada\u00a0P (2016) Brugada syndrome in the paediatric population: a\u00a0comprehensive approach to clinical manifestations, diagnosis, and management. Cardiol Young 26(6):1044\u20131055","journal-title":"Cardiol Young"},{"issue":"17","key":"1098_CR30","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/heartjnl-2012-301784","volume":"98","author":"P Chockalingam","year":"2012","unstructured":"Chockalingam\u00a0P, Wilde\u00a0A (2012) The multifaceted cardiac sodium channel and its clinical implications. Heart 98(17):1318\u20131324","journal-title":"Heart"},{"issue":"2","key":"1098_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1017\/S1047951112001138","volume":"23","author":"G Sarquella-Brugada","year":"2013","unstructured":"Sarquella-Brugada\u00a0G, Campuzano\u00a0O, Iglesias\u00a0A, Sanchez-Malagon\u00a0J, Guerra-Balic\u00a0M et\u00a0al (2013) Genetics of sudden cardiac death in children and young athletes. Cardiol Young 23(2):159\u2013173","journal-title":"Cardiol Young"},{"issue":"4","key":"1098_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.hrthm.2005.01.005","volume":"2","author":"C Antzelevitch","year":"2005","unstructured":"Antzelevitch\u00a0C, Brugada\u00a0P, Borggrefe\u00a0M, Brugada\u00a0J, Brugada\u00a0R et\u00a0al (2005) Brugada syndrome: report of the second consensus conference. Heart Rhythm 2(4):429\u2013440","journal-title":"Heart Rhythm"},{"issue":"15","key":"1098_CR33","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1161\/CIRCULATIONAHA.106.664219","volume":"115","author":"V Probst","year":"2007","unstructured":"Probst\u00a0V, Denjoy\u00a0I, Meregalli\u00a0PG, Amirault\u00a0JC, Sacher\u00a0F et\u00a0al (2007) Clinical aspects and prognosis of Brugada syndrome in children. Circulation 115(15):2042\u20132048","journal-title":"Circulation"},{"issue":"5","key":"1098_CR34","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","volume":"121","author":"V Probst","year":"2010","unstructured":"Probst\u00a0V, Veltmann\u00a0C, Eckardt\u00a0L, Meregalli\u00a0PG, Gaita\u00a0F et\u00a0al (2010) Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry. Circulation 121(5):635\u2013643","journal-title":"Circulation"},{"issue":"1","key":"1098_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","volume":"59","author":"SG Priori","year":"2012","unstructured":"Priori\u00a0SG, Gasparini\u00a0M, Napolitano\u00a0C, Bella\u00a0DP, Ottonelli\u00a0AG et\u00a0al (2012) Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J\u00a0Am Coll Cardiol 59(1):37\u201345","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1098_CR36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1046\/j.1540-8167.2003.02517.x","volume":"14","author":"P Brugada","year":"2003","unstructured":"Brugada\u00a0P, Brugada\u00a0R, Mont\u00a0L, Rivero\u00a0M, Geelen\u00a0P et\u00a0al (2003) Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol 14(5):455\u2013457","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"1098_CR37","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1161\/CIRCEP.115.003256","volume":"8","author":"K Guerrier","year":"2015","unstructured":"Guerrier\u00a0K, Kwiatkowski\u00a0D, Czosek\u00a0RJ, Spar\u00a0DS, Anderson\u00a0JB et\u00a0al (2015) Short QT interval prevalence and clinical outcomes in a\u00a0pediatric population. Circ Arrhythm Electrophysiol 8(6):1460\u20131464","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"1098_CR38","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jacc.2010.09.048","volume":"57","author":"MH Gollob","year":"2011","unstructured":"Gollob\u00a0MH, Redpath\u00a0CJ, Roberts\u00a0JD (2011) The short QT syndrome: proposed diagnostic criteria. J\u00a0Am Coll Cardiol 57(7):802\u2013812","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1098_CR39","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/europace\/euab097","volume":"23","author":"H Suzuki","year":"2021","unstructured":"Suzuki\u00a0H, Horie\u00a0M, Ozawa\u00a0J, Sumitomo\u00a0N, Ohno\u00a0S et\u00a0al (2021) Novel electrocardiographic criteria for short QT syndrome in children and adolescents. Europace 23(12):2029\u20132038","journal-title":"Europace"},{"issue":"13","key":"1098_CR40","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jacc.2013.09.078","volume":"63","author":"A Mazzanti","year":"2014","unstructured":"Mazzanti\u00a0A, Kanthan\u00a0A, Monteforte\u00a0N, Memmi\u00a0M, Bloise\u00a0R et\u00a0al (2014) Novel insight into the natural history of short QT syndrome. J\u00a0Am Coll Cardiol 63(13):1300\u20131308","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1098_CR41","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4103\/0974-2069.164695","volume":"8","author":"SP Behere","year":"2015","unstructured":"Behere\u00a0SP, Weindling\u00a0SN (2015) Inherited arrhythmias: The cardiac channelopathies. Ann Pediatr Cardiol 8(3):210\u2013220","journal-title":"Ann Pediatr Cardiol"},{"issue":"12","key":"1098_CR42","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","volume":"10","author":"SG Priori","year":"2013","unstructured":"Priori\u00a0SG, Wilde\u00a0AA, Horie\u00a0M, Cho\u00a0Y, Behr\u00a0ER et\u00a0al (2013) HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10(12):1932\u20131963","journal-title":"Heart Rhythm"},{"key":"1098_CR43","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3389\/fphar.2019.00771","volume":"10","author":"I El-Battrawy","year":"2019","unstructured":"El-Battrawy\u00a0I, Besler\u00a0J, Li\u00a0X, Lan\u00a0H, Zhao\u00a0Z et\u00a0al (2019) Impact of Antiarrhythmic drugs on the outcome of short QT syndrome. Front Pharmacol 10:771","journal-title":"Front Pharmacol"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-025-01098-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-025-01098-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-025-01098-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:47:40Z","timestamp":1782917260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-025-01098-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1098"],"URL":"https:\/\/doi.org\/10.1007\/s00399-025-01098-2","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"U.\u00a0Krause declares that he has no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}